TITLE

Ocular surface disease needs to be managed before and after surgery

AUTHOR(S)
Lindstrom, Richard L.
PUB. DATE
December 2009
SOURCE
Ocular Surgery News;12/10/2009, Vol. 27 Issue 23, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The author emphasizes the importance of managing ocular surface diseases, which include dry eye, blepharitis and ocular allergy, before and after surgery. He argues that a new test for tear film osmolarity from TearLab has the potential to enhance the ability of technicians to screen for aqueous deficient or evaporative dry eye. He recommends several strategies for ocular surface diseases based on his experiences.
ACCESSION #
45566946

 

Related Articles

  • Ophthalmic insert offers additional relief as adjunct dry eye therapy. Petrou, Ilya; Koffler, Bruce H. // Ophthalmology Times;2/15/2010, Vol. 35 Issue 4, p32 

    The article offers information on the additional relief of ophthalmic insert in long-term adjunct dry eye therapy. It notes that the use of proprietary hydroxypropyl cellulose ophthalmic insert proved to offer much relief to patients with dry eye syndrome. According to Dr. Bruce H. Koffler,...

  • DED researchers examine its complexities, recommend treatment based on severity. Meszaros, Liz; Dunlap, Karen // Optometry Times;Sep2012, Vol. 4 Issue 9, p18 

    The article focuses on the classification and treatment of patients with dry eye disease (DED). Doctor Karen Dunlap of Wilmer Eye Institute says that the diagnosis, management, and treatment of DED have continued to overwhelm clinicians. In 2006, the Delphi Panel classified the various causes of...

  • Beyond the Basics: Treating Severe Dry Eye. Townsend, William F. // Review of Cornea & Contact Lenses;Jan/Feb2010, Vol. 147 Issue 1, p26 

    The article discusses the treatment options for severe dry eye. The views of experts on the causes of dry eye are highlighted. Clinical information on severe dry eye is provided, including its clinical manifestations, consequences and types. According to the author, various artificial tear...

  • Punctum plugs: Often the last resort in dry eye treatment. Vasta, Stephanie // Primary Care Optometry News;Nov2008, Vol. 13 Issue 11, p16 

    The article examines the use of punctum plugs as a last resort in the treatment for dry eye. It shares that practitioners resort to punctal occlusion only after topical therapy and management of environmental factors as well as resolution of systemic issues have failed to improve the signs and...

  • hydroxyethylcellulose.  // Royal Society of Medicine: Medicines;2002, p291 

    The article presents information on hydroxyethylcellulose, a constituent of a preparation drug used as artificial tears which is given to patients with dry eyes due to a disease. This drug is administered orally and is regarded as safe in normal topical use.

  • What to Expect from Your Dry-Eye Device. Bethke, Walter // Review of Ophthalmology;Oct2015, Vol. 22 Issue 10, p48 

    The article discusses the non-invasive treatment devices that were developed for the dry eye condition. Topics include a description of the non-invasive treatment devices such as LipiFlow and intense pulsed light, an overview of the study on these non-invasive treatment devices, and the insights...

  • It's the Thought that Counts. Ousler, George; Smith, Lisa; Chapin, Matthew // Review of Ophthalmology;Nov2015, Vol. 22 Issue 11, p6 

    The article discusses how pharmaceutical company BioLight developed ophthalmology products to diagnose and treat dry-eye disease. Dry-eye disease is defined as a dysfunction in the tear film, resulting in suppressed tear production in patients. Since dry-disease is described as a multifactorial...

  • Topical cyclosporine A efficacious in treatment of severe trachomatous dry eye.  // Ocular Surgery News;11/10/2009, Vol. 27 Issue 21, p34 

    The article discusses research which confirmed the efficacy of topical cyclosporine A in treating severe trachomatous dry eye. It references a study which appeared in "Clinical & Experimental Ophthalmology." It describes the treatment received by patients with severe trachomatous dry eye. The...

  • Concomitant use of tear products with cyclosporine assessed. Groves, Nancy; Guenena, Mohamed A. // Ophthalmology Times;2/15/2010, Vol. 35 Issue 4, p34 

    The article presents a comparison study that assesses the concomitant use of tear products with cyclosporine. It cites that the subjects consists of 50 eyes of 25 patients 18-years or older diagnosed with chronic dry eye and had been using cyclosporine for at least 3 months. It concludes that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics